NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIBIB E-006-2020-0-US-01 SYSTEMS AND METHODS FOR MULTIVIEW SUPER-RESOLUTION MICROSCOPY US 63/001,691 Abandoned
NIBIB E-006-2020-1-US-01 SYSTEMS AND METHODS FOR OPTICAL REASSIGNMENT IN MULTIVIEW SUPER-RESOLUTION MICROSCOPY US 63/001,672 Abandoned
NIDCR E-047-2020-0-US-01 METHOD FOR BLOCKING UPTAKE OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-TARGETED RADIONUCLIDES BY EXOCRINE ORGANS US 63/001,681 Abandoned
NIAID E-182-2020-2-US-01 CORONAVIRUS RNA VACCINES US 63/002,094 Abandoned
NCI E-182-2017-0-IL-07 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION IL National Stage 273698 Pending
NCI E-237-2017-2-NZ-14 T CELL RECEPTORS RECOGNIZING MUTATED P53 NZ National Stage 763023 Pending
NIAID E-097-2020-0-JP-08 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE JP National Stage 2022-557764 Issued
NCI E-237-2017-2-US-16 T CELL RECEPTORS RECOGNIZING MUTATED P53 US National Stage 16/651,242 11939365 Issued PDF
NIAID E-097-2020-0-PCT-01 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE PCT PCT PCT/US2020/024985 Expired
NIAID E-097-2020-0-EP-06 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE EP National Stage 20719313.7 Pending
NCI E-133-2017-0-EP-03 IN VITRO GENERATION OF THYMIC ORGANOID FROM HUMAN PLURIPOTENT STEM CELLS EP National Stage 18783234.0 Pending
NIAID E-097-2020-0-IN-07 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE IN National Stage 202217058054 Pending
NIAID E-097-2020-0-CA-05 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE CA National Stage 3174779 Pending
NCATS E-157-2020-0-US-01 METHODS OF TREATING CORONAVIRUS INFECTIONS US 63/000,425 Abandoned
NIAID E-097-2020-0-BR-04 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE BR National Stage BR112022017512-4 Pending
NIAID E-097-2020-0-AU-03 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE AU National Stage 2020437669 Pending
NCI E-237-2017-1-US-11 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION US National Stage 16/650,696 Pending
NHLBI E-196-2017-0-US-03 POLYDOPAMINE-ENCAPSULATED NANODIAMONDS AND METHODS US National Stage 16/650,507 Abandoned
NCI E-102-2020-0-US-01 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY US 62/992,715 Abandoned
NCI E-061-2020-0-US-01 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY US 62/992,701 Abandoned
NCI E-181-2017-0-NZ-19 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS NZ National Stage 762831 Pending
NCI E-084-2019-0-EP-03 Automated Device With Integrated Histology Tissue Sectioning, Staining, And Scanning For High Throughput Demand EP National Stage 20772823.9 Pending
NCI E-084-2019-0-KR-07 Automated Device With Integrated Histology Tissue Sectioning, Staining, And Scanning For High Throughput Demand KR National Stage 10-2021-7033539 Pending
NCI E-084-2019-0-CN-06 Automated Device With Integrated Histology Tissue Sectioning, Staining, And Scanning For High Throughput Demand CN National Stage 202080023309.6 Pending
NCI E-084-2019-0-PCT-02 Automated Device With Integrated Histology Tissue Sectioning, Staining, And Scanning For High Throughput Demand PCT PCT PCT/US2020/023644 Expired
NCI E-231-2017-0-US-03 IMMUNOTOXINS WITH ALBUMIN BINDING DOMAIN US National Stage 16/648,369 11795235 Issued PDF
NCI E-133-2017-0-JP-04 IN VITRO GENERATION OF THYMIC ORGANOID FROM HUMAN PLURIPOTENT STEM CELLS JP National Stage 2020-516436 Issued
NCI E-104-2013-0-US-05 ANTI-CD276 POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS US CON 16/823,218 11512138 Issued PDF
NCI E-133-2017-0-US-05 IN VITRO GENERATION OF THYMIC ORGANOID FROM HUMAN PLURIPOTENT STEM CELLS US National Stage 16/648,008 11898166 Issued PDF
NCI E-099-2014-0-US-12 USES OF MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS US DIV 16/821,674 11702472 Issued PDF
NCI E-234-2014-1-KR-01 B T METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF KR DIV 10-2020-7007771 Abandoned
NIDDK E-101-2020-0-US-01 ANTIBACTERIAL AND ANTIFUNGAL POLYKETIDES FROM ENVIRONMENTAL AMYCOLATOPSIS SPP US 62/990,557 Abandoned
NCI E-210-2018-0-PCT-02 CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY PCT PCT PCT/US2020/022752 Expired
NCI E-210-2018-0-CN-04 CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY CN National Stage 202080021582.5 Pending
NCI E-210-2018-0-HK-05 CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY HK EP 62022051308.4 Pending
NCI E-210-2018-0-EP-03 CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY EP National Stage 20718061.3 Pending
NIAID E-095-2019-0-EP-03 HIV RNA VACCINES EP National Stage 20773323.9 Pending
NIAID E-095-2019-0-PCT-02 Induction Of Protective Immunity To HIV By An MRNA-based Vaccine PCT PCT PCT/US2020/022710 Expired
NIAMS E-192-2017-0-CN-03 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF HEPATITIS B VIRUS INFECTION CN National Stage 201880059238.8 Issued
NCI E-075-2020-0-US-01 SYSTEMS, METHODS, AND DEVICES FOR EX VIVO ANALYSIS OF RESECTED TISSUE SAMPLES US 62/988,783 Abandoned
NIAID E-168-2020-1-US-01 Corona Virus Binders US 62/988,610 Expired
NCATS E-118-2019-0-EP-03 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF EP National Stage 20794764.9 Issued
NCI E-190-2014-0-AU-45 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS AU DIV 2020201799 Issued
NCI E-080-2020-0-US-01 USE OF ISOVALERYLSPIRAMYCINS AS ANTI-CANCER AGENTS TO INHIBIT METASTASIS US ORD 16/816,068 11351185 Issued PDF
NCATS E-118-2019-0-JP-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF JP National Stage 2021-563609 Pending
NCATS E-118-2019-0-PCT-02 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF PCT PCT PCT/US2020/022072 Expired
NCATS E-118-2019-0-AU-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF AU National Stage 2020264106 Pending
NCATS E-004-2016-1-US-01 Substituted Bicyclic Heteroaryl Inhibitors Of Bromodomain-containing Protein BRD4 US 62/988,206 Abandoned
NCATS E-118-2019-0-CA-04 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF CA National Stage 3137870 Pending
NCI E-250-2014-0-US-08 ANTI-CD276 ANTIBODIES (B7H3) US DIV 16/812,980 11851498 Issued PDF